News

Glivec is used in the treatment of a rapidly progressive leukemia and hard-to-treat solid cancer tumors. Both are rare and potentially life-threatening diseases with few, if any, approved

The agreement comes after positive preclinical trials for the products which are focused on the treatment of neurological diseases such as Alzheimer’s. The previous success of the partnership

Epirubicin is a chemotherapy drug that is given as a treatment for many different types of cancer and is administered by injection. Epirubicin, sold under the brand name

Auriga commented that Xerostomia could represent a potential marketplace estimated at more than $1 billion. The current size of the prescription marketplace for xerostomia medications is at approximately

The sum of payment has not been published but under the terms of the agreement, Alcon Manufacturing will make an up front payment to NovaCal. Alcon will also

Data from a trial revealed that after a 24 month observation period there was improved bone growth in the patients treated with GEM 21S. GEM 21S works by

The compound has been granted fast track status by the FDA in this patient population. Tykerb is a small molecule dual kinase inhibitor developed by GSK as an

Linda Reeves was the plaintiff who was diagnosed with breast cancer after the use of the hormone therapy Prempro. This was the first case of a series of

Pfizer will receive exclusive worldwide rights to commercialize TransTech's portfolio of compounds, while TransTech will receive upfront and milestone payments of $155 million with the potential for more.